Superenhancer Analysis Defines Novel Epigenomic Subtypes of Non-APL AML, Including an RARα Dependency Targetable by SY-1425, a Potent and Selective RARα Agonist

Michael R. McKeown, Ravindra Majeti, Matthew G. Guenther et al.|Cancer Discovery|2017

Cited by 139